• 1. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 2. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 3. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

Comprehensive Guide to (4-Chloro-3,5-dimethoxyphenyl)boronic acid (CAS No. 427886-21-3): Properties, Applications, and Market Insights

(4-Chloro-3,5-dimethoxyphenyl)boronic acid (CAS No. 427886-21-3) is a specialized boronic acid derivative widely used in organic synthesis, pharmaceutical research, and material science. This compound, characterized by its chloro and dimethoxy substituents, plays a pivotal role in Suzuki-Miyaura cross-coupling reactions, a cornerstone of modern synthetic chemistry. With the increasing demand for high-purity intermediates in drug discovery, this boronic acid has garnered significant attention from researchers and manufacturers alike.

The molecular structure of (4-Chloro-3,5-dimethoxyphenyl)boronic acid features a boron atom bonded to a phenyl ring substituted with chloro and methoxy groups at positions 4, 3, and 5, respectively. This unique arrangement enhances its reactivity in palladium-catalyzed coupling reactions, making it invaluable for constructing complex biaryl structures. Recent studies highlight its growing applications in developing OLED materials and pharmaceutical intermediates, aligning with current trends in green chemistry and sustainable synthesis.

In pharmaceutical applications, (4-Chloro-3,5-dimethoxyphenyl)boronic acid serves as a key building block for kinase inhibitors and anticancer agents. Researchers are particularly interested in its potential for creating targeted therapies, especially in the context of precision medicine. The compound's stability under various conditions makes it suitable for high-throughput screening and combinatorial chemistry, addressing the pharmaceutical industry's need for diverse molecular scaffolds.

The material science sector has also embraced (4-Chloro-3,5-dimethoxyphenyl)boronic acid for developing advanced polymeric materials and electronic components. Its ability to form stable boronate esters has been exploited in creating self-healing materials and sensors, topics currently trending in nanotechnology research. The compound's electron-donating methoxy groups contribute to its utility in designing organic semiconductors, particularly for flexible electronics applications.

From a market perspective, the demand for (4-Chloro-3,5-dimethoxyphenyl)boronic acid has shown steady growth, driven by expanding bioconjugation techniques and drug discovery programs. Manufacturers are focusing on improving synthetic routes to enhance yield and purity while reducing environmental impact. The compound's compatibility with microwave-assisted synthesis and flow chemistry systems makes it particularly attractive for modern high-efficiency laboratories.

Quality control of (4-Chloro-3,5-dimethoxyphenyl)boronic acid typically involves advanced analytical techniques such as HPLC, NMR spectroscopy, and mass spectrometry. The pharmaceutical-grade material must meet stringent impurity profile requirements, especially when used in GMP-compliant synthesis. Recent advancements in analytical methodology have enabled more precise characterization of this compound, ensuring its suitability for critical applications.

Storage and handling recommendations for (4-Chloro-3,5-dimethoxyphenyl)boronic acid emphasize protection from moisture and oxygen, typically achieved through argon-filled packaging and desiccated storage conditions. While stable under normal laboratory conditions, the compound's boronic acid moiety requires careful consideration when planning long-term storage or transportation protocols.

Current research trends involving (4-Chloro-3,5-dimethoxyphenyl)boronic acid explore its potential in biomedical imaging and theragnostic applications. Scientists are investigating its incorporation into PET tracer molecules and fluorescent probes, capitalizing on the growing interest in multimodal imaging agents. These developments position the compound at the forefront of diagnostic and therapeutic innovation.

The synthesis of (4-Chloro-3,5-dimethoxyphenyl)boronic acid typically proceeds through lithiation-borylation sequences or transmetalation reactions from corresponding halides. Recent process optimization efforts have focused on catalyst recycling and solvent reduction, addressing the chemical industry's push toward greener synthetic protocols. These improvements have significantly enhanced the compound's sustainability profile without compromising quality.

Looking ahead, (4-Chloro-3,5-dimethoxyphenyl)boronic acid is poised to maintain its importance in cutting-edge research and industrial applications. Its versatility in molecular construction and compatibility with diverse reaction conditions ensure its continued relevance across multiple scientific disciplines. As synthetic methodologies evolve and new applications emerge, this compound will likely play an increasingly vital role in advanced material development and pharmaceutical innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)